Call us today 212-583-0100

Press Releases

Please view the latest press from Enzo Biochem, Inc.

Date Details
Tuesday October 12, 2021 Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
Tuesday September 28, 2021 Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th
Thursday September 02, 2021 ENZO BIOCHEM TO PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE
Tuesday July 20, 2021 ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
Tuesday June 15, 2021 Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
Wednesday June 09, 2021 Enzo Biochem Reports Third Quarter Fiscal 2021 Results
Tuesday June 01, 2021 Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
Wednesday April 21, 2021 Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
Wednesday March 17, 2021 ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
Monday March 15, 2021 Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
Thursday March 04, 2021 Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
Tuesday March 02, 2021 Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants
Monday March 01, 2021 Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
Wednesday February 03, 2021 Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
Wednesday January 20, 2021 ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES
Tuesday January 05, 2021 ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT
Monday January 04, 2021 ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2

To view releases from previous years, select the year below that you would like to see. You may chose to view the latest news or reports dating back to 2003.